Generated by AI
Eocene Ltd. is an Israel-based biopharmaceutical and medtech company focused on gastrointestinal disease management and related therapeutic areas. The company develops pharmaceutical and device-based solutions for conditions such as liver disorders, gastrointestinal oncology, and colorectal care. Its portfolio includes Aramchol, an oral therapeutic candidate being developed for liver-related indications, as well as medical device technologies designed to support postoperative colorectal treatment. Eocene Ltd. combines research, clinical development, and product commercialization activities across its healthcare platform, with operations centered in Ramat Gan, Israel. The company serves a niche role in the biotechnology market by pursuing therapies and technologies aimed at unmet needs in gastrointestinal and adjacent medical fields.
Website16 Abba Hillel Road
Ramat Gan, 5250608
Israel
The latest articles about GLMD.
Detailed price information for Galmed Pharmaceutica (GLMD-Q) from The Globe and Mail including charting and trades.
Summary of Aug 19's posts. Generated by AI.
Summary of Jun 8's posts. Generated by AI.
Summary of May 15's posts. Generated by AI.
Summary of Jul 16's posts. Generated by AI.
Investors talking about GLMD also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.